Lv5
936 积分 2024-07-31 加入
Co-activating the intrinsic FcRγ/TLR4 signaling axis enhances the antitumor activity of NKG2D CAR-macrophages against prostate cancer
26天前
已完结
Generation of chimeric antigen receptor-macrophages by using human induced pluripotent stem cells
26天前
已完结
Synergically enhanced anti-tumor immunity of in vivo panCAR by circRNA vaccine boosting
26天前
已完结
3D-printed implantable CAR-macrophages for post-surgery cancer immunotherapy
26天前
已完结
Hierarchical Zeolitic Imidazolate Framework-8@Au Cluster Nanocarriers for In Situ Chimeric Antigen Receptor Macrophage Programming and Immunotherapy in Prostate Cancer
26天前
已完结
An in situ engineered chimeric IL-2 receptor potentiates the tumoricidal activity of proinflammatory CAR macrophages in renal cell carcinoma
26天前
已完结
Advancing Tumor-Targeted Chemo-Immunotherapy: Development of the CAR-M-derived Exosome-Drug Conjugate
26天前
已完结
CD86 costimulation enhances the antitumor activity of NKG2D CAR-Macrophages and synergizes with Anti-PD-L1 therapy to suppress prostate cancer progression
26天前
已完结
Breaking the immunosuppressive barrier: an armored CAR-M biotechnology with the original M1 phenotype dominance rescues antitumor immunity
26天前
已完结
Targeting inflammation with chimeric antigen receptor macrophages using a signal switch
26天前
已完结
皖公网安备34019202002308
